Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Ilonca

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Nuclear Medicine|November 7, 2009
Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CTDenis Mariano-Goulart, Diana Ilonca, Aurélie Bourdon
Diagnostics (Basel, Switzerland)|April 23, 2022
Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?Marie-Claude Eberlé, Cyril Fersing, Sophie Guillemard, et al.
Clinical Nuclear Medicine|June 25, 2024
LYMPHOSCORE (Lymphoscintigraphy Scoring Reliability) Reliability of a New Qualitative and Semiquantitative Lymphoscintigraphy Scoring System for Primary LymphedemaSophie Guillemard, Lionel Moulis, Diana Ilonca, et al.
Clinical Nuclear Medicine|January 22, 2010
FDG PET/CT in aortic angiosarcomaLouis Sibille, Diana Ilonca, Eric Oziol, et al.
Clinical Case Reports|September 12, 2025
Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [<sup>18</sup>F]FDG PET/CT, 20 Years After Primary Diagnosis: A Case ReportAlina Diana Ilonca, Amélie Gudin-de-Vallerin, Sophie Guillemard, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 16, 2018
Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaCarole Allimant, Marilyne Kafrouni, Julien Delicque, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body-Surface-Area Model to Predict Delivered Dose and Radioembolization OutcomeMarilyne Kafrouni, Carole Allimant, Marjolaine Fourcade, et al.
Nutrients|July 14, 2023
Identification of <sup>18</sup>F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal CancerThierry Galvez, Ikrame Berkane, Simon Thézenas, et al.
Annals of Translational Medicine|April 3, 2023
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?Caterina Cusumano, Emmanuel Deshayes, Boris Guiu, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Nuclear Medicine|November 7, 2009
Diagnosis of silent myocardial ischemia during the staging of HIV-associated lymphoma with FDG PET/CTDenis Mariano-Goulart, Diana Ilonca, Aurélie Bourdon
Diagnostics (Basel, Switzerland)|April 23, 2022
Unusual Focal Lung Uptake without CT Abnormality on a Bone Scan: What Might It Mean?Marie-Claude Eberlé, Cyril Fersing, Sophie Guillemard, et al.
Clinical Nuclear Medicine|June 25, 2024
LYMPHOSCORE (Lymphoscintigraphy Scoring Reliability) Reliability of a New Qualitative and Semiquantitative Lymphoscintigraphy Scoring System for Primary LymphedemaSophie Guillemard, Lionel Moulis, Diana Ilonca, et al.
Clinical Nuclear Medicine|January 22, 2010
FDG PET/CT in aortic angiosarcomaLouis Sibille, Diana Ilonca, Eric Oziol, et al.
Clinical Case Reports|September 12, 2025
Gastric Metastases From Invasive Breast Lobular Carcinoma, Identified by [<sup>18</sup>F]FDG PET/CT, 20 Years After Primary Diagnosis: A Case ReportAlina Diana Ilonca, Amélie Gudin-de-Vallerin, Sophie Guillemard, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 16, 2018
Tumor Targeting and Three-Dimensional Voxel-Based Dosimetry to Predict Tumor Response, Toxicity, and Survival after Yttrium-90 Resin Microsphere Radioembolization in Hepatocellular CarcinomaCarole Allimant, Marilyne Kafrouni, Julien Delicque, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 17, 2018
Retrospective Voxel-Based Dosimetry for Assessing the Ability of the Body-Surface-Area Model to Predict Delivered Dose and Radioembolization OutcomeMarilyne Kafrouni, Carole Allimant, Marjolaine Fourcade, et al.
Nutrients|July 14, 2023
Identification of <sup>18</sup>F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal CancerThierry Galvez, Ikrame Berkane, Simon Thézenas, et al.
Annals of Translational Medicine|April 3, 2023
Prevention of post-hepatectomy liver failure after major resection of colorectal liver metastases: is hepato-biliary scintigraphy the optimal tool?Caterina Cusumano, Emmanuel Deshayes, Boris Guiu, et al.
The Lancet. Oncology|November 7, 2017
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trialValérie Vilgrain, Helena Pereira, Eric Assenat, et al.
Pageof 1